Men's Health:Testosterone Deficiency- 17th November 2021 - 12.30pm to 1.30pm
The consensus is that:
TD is a
well–established, significant medical condition that negatively affects male
sexuality, reproduction, general health, and quality of life; 2) Symptoms and
signs of TD occur as a result of low levels of testosterone, and may benefit
from treatment regardless of whether there is an identified underlying
etiology; 3) TD is a global public health concern; 4) T therapy for men with TD
is effective, rational, and evidence-based; 5) There is no T concentration
threshold that reliably distinguishes those who will respond to treatment from
those who will not; 6) There is no scientific basis for any age-specific recommendations
against the use of T therapy in adult men; 7) The evidence does not support
increased risks of cardiovascular events with T therapy; 8) The evidence does
not support increased risk of prostate cancer with T therapy; 9) The evidence
supports a major research initiative to explore possible benefits of T therapy
for cardiometabolic disease, including diabetes.
We shall discuss.
This course is being run as an online training course. Details of how to
join the meeting will be emailed to you closer to the event.